HLA typing demands for peptide-based anti-cancer vaccine.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- HLA typing demands for peptide-based anti-cancer vaccine.
- Published In:
- Cancer immunology, immunotherapy : CII, 57(12), 1903-10 (2008)
- Authors:
- Nagorsen, Dirk, Thiel, Eckhard
- Database ID:
- RPEP-01390
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01390APA
Nagorsen, Dirk; Thiel, Eckhard. (2008). HLA typing demands for peptide-based anti-cancer vaccine.. Cancer immunology, immunotherapy : CII, 57(12), 1903-10. https://doi.org/10.1007/s00262-008-0493-6
MLA
Nagorsen, Dirk, et al. "HLA typing demands for peptide-based anti-cancer vaccine.." Cancer immunology, 2008. https://doi.org/10.1007/s00262-008-0493-6
RethinkPeptides
RethinkPeptides Research Database. "HLA typing demands for peptide-based anti-cancer vaccine." RPEP-01390. Retrieved from https://rethinkpeptides.com/research/nagorsen-2008-hla-typing-demands-for
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.